CALR and acquired polycythemia vera: The value to recognize early and distinct phases of diseases, through the characterization of as homogeneous as possible clinical, histopathology and molecular patterns (for example, CALR mutation is very unlikely to indicate PV, if not exceptionally108, and MPL mutation virtually negates it), is projected to improve the management and hopefully the outcome.